Overview

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The BOHEMIA program consists of a combination of studies organized around a central community prevention mass drug administration protocol and four sub-studies (i.e.; social science, entomology, health economics, and environmental), each written as an individual protocol. The protocol is central but used in two separate, individually powered trials in Mozambique and Tanzania. The trials have been powered on the efficacy outcome and designed to meet the requirements of WHO´s preferred product characteristics (PPC) for endectocides.
Phase:
Phase 3
Details
Lead Sponsor:
Barcelona Institute for Global Health
Collaborator:
UNITAID
Treatments:
Albendazole
Ivermectin